The Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Growth Accelerated by Increasing Incidence of COPD Cases

 


Chronic Obstructive Pulmonary Disease (COPD) refers to a group of lung diseases including chronic bronchitis and emphysema. It causes persistent symptoms and airflow limitation due to exposure to toxic gases or particles. Inhalers and nebulizers are commonly used to manage COPD symptoms.

The global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market is estimated to be valued at US$ 20.86 Mn in 2024 and is expected to exhibit a CAGR of 6.1% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
Rising prevalence of smoking and growing pollution levels have resulted in a marked increase in COPD incidence rates globally. According to the World Health Organization, COPD is projected to become the third leading cause of death worldwide by 2030. With growing COPD patient pools, demand for medications and devices to manage the condition is also witnessing considerable growth. Advancements in portable inhalers and wearable nebulizers further allow for improved treatment convenience and compliance. Increased R&D focus on developing more effective therapeutics for COPD treatment also augurs well for market expansion over the forecast period.


Segment Analysis
The global chronic obstructive pulmonary disease (COPD) treatment market growth is dominated by drug therapies segment. Drugs such as bronchodilators, corticosteroids, and combinations account for majority of the market share due to lower costs and proven efficacy in managing COPD symptoms. Bronchodilators dominate the drug therapies segment due to their extensive use in both relieving symptoms as well as preventing exacerbations.

Key Takeaways
The global chronic obstructive pulmonary disease (COPD) treatment market is expected to witness high growth during the forecast period of 2024 to 2031. The global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market is estimated to be valued at US$ 20.86 Mn in 2024 and is expected to exhibit a CAGR of 6.1% over the forecast period 2024 to 2031.

Regional analysis: North America currently dominates the global COPD treatment market owing to high prevalence and diagnosis rates of COPD in the region. However, Asia Pacific region is expected to grow at the fastest pace due to rapidly improving healthcare infrastructure and increasing pollution levels in densely populated countries such as China and India.

Key players: Key players operating in the chronic obstructive pulmonary disease (COPD) treatment market are First Sensor AG, Bosch Sensortec GmbH, Honeywell International Inc., Murata Manufacturing Co. Ltd., ROHM Co. Ltd., Amphenol Corporation, InvenSense Inc. (TDK Corporation), Sensata Technologies Inc., NXP Semiconductors NV (Freescale), Goertek Inc., TE Connectivity Ltd., STMicroelectronics NV, Infineon Technologies AG, Omron Corporation, and Alps Alpine Co. Ltd.

Get more insights on this topic: https://www.ukwebwire.com/chronic-obstructive-pulmonary-disease-copd-treatment-market-share-and-opportunity-analysis/

Comments

Post a Comment

Popular posts from this blog

Blast Chillers Market Poised to Witness High Growth Owing to Rising Focus on Food Safety

Image
  Blast Chillers Market Blast chillers, also known as shock freeze machines, are appliances used to quickly cool or freeze food items that have been cooked. Blast chillers allow rapid and accurate chilling of cooked or cooked/hot foods quickly to temperatures that inhibit the growth of harmful bacteria. This rapid chilling process helps restaurants, cafes, caterers and foodservice distributors maintain food quality as well as meet critical food safety regulations. Blast chillers help in preserving the look, texture, flavor and nutritional value of foods even after rapid chilling. They extend the shelf life of cooked foods by preventing bacterial growth in the food's temperature danger zone — between 4°C and 60°C. With increasing focus on food safety, hygiene and quality across the foodservice industry, demand for blast chillers has been rising significantly. The Global blast chillers market is estimated to be valued at US$ 2.24 Bn in 2024 and is expected to exhibit a CAGR of 15%...
Read more

Driving Forces and Strategic Insights: Unveiling Growth Opportunities in the Global Pharma 4.0 Market

Image
  Global Pharma 4.0 Market The Global Pharma 4.0 Market is witnessing unprecedented growth driven by several factors. One of the key market drivers is the increasing adoption of digitalization and automation in the pharmaceutical industry. Pharma 4.0 represents the integration of advanced technologies such as artificial intelligence, big data analytics, Internet of Things (IoT), and robotics into pharmaceutical manufacturing and supply chain processes. This integration enhances efficiency, reduces costs, and improves the quality of pharmaceutical products. Additionally, the rising demand for personalized medicine and the need for efficient drug development processes are further fueling the growth of the Global Pharma 4.0 Market. The Global Pharma 4.0 Market is estimated to be valued at   US$ 54.43 Bn in 2024 and is expected to exhibit a CAGR of 18.3% over the forecast period from 2024 to 2031.   Conducting a PEST analysis provides insights into the external facto...
Read more

Navigating Growth: Insights into the Global Flea, Tick, and Heartworm Products Market

Image
  Global Flea, Tick, and Heartworm Products Market The Global Flea, Tick, and Heartworm Products Market have witnessed robust growth in recent years, driven by several key factors. Market drivers such as increasing pet ownership, rising awareness about pet health, and the growing prevalence of flea, tick, and heartworm infections among pets are propelling the demand for related products. Furthermore, advancements in veterinary medicines and the introduction of novel products with improved efficacy are augmenting market growth. The rising disposable income and changing lifestyles, particularly in emerging economies, have also contributed significantly to the expansion of the Global Flea, Tick, and Heartworm Products Market. The Global Flea, Tick, and Heartworm Products Market is estimated to be valued at US$ 3.14 Bn in 2024 and is expected to exhibit a CAGR of 8.5% over the forecast period 2024 to 2031. Conducting a PEST analysis provides valuable insights into the external f...
Read more